Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Classical hematology 1

Conditions

Thrombocytopenia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

fludarabine phosphate 10Cyclophosphamide 8Cyclosporine 7Whole-Body Irradiation 6Mycophenolic Acid 5Peripheral Blood Stem Cell Transplantation 4Therapeutics 3Filgrastim 3Epoetin Alfa 3Darbepoetin alfa 3Cord Blood Stem Cell Transplantation 3Antilymphocyte Serum 3fludarabine 2Thiotepa 2Etoposide 2Cyclosporins 2Busulfan 2laromustine 1ferrous sulfate 1ferric gluconate 1alvocidib 1Vincristine 1Valganciclovir 1Tetradecanoylphorbol Acetate 1Tacrolimus 1Sucrose 1Sirolimus 1Rituximab 1Prednisone 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Prolymphocytic × alvocidib × Classical hematology × Clear all
NCT00735930 2015-04-02

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡